使用 Eribulin 的乳腺癌患者绝对淋巴细胞计数和中性粒细胞/淋巴细胞比率在不同时期的变化趋势

{"title":"使用 Eribulin 的乳腺癌患者绝对淋巴细胞计数和中性粒细胞/淋巴细胞比率在不同时期的变化趋势","authors":"M.X. Su, H.W. Lin, H.T.H. Nguyen, T.C. Lin, C.J. Chen, H.C. Wang, C.T. Wu, Y. Wu, G.Y. He, L.C. Liu, C.H. Huang","doi":"10.1016/j.ejca.2024.113705","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"34 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Trends of Absolute Lymphocyte Count and Neutrophil/Lymphocyte Ratio across Times among Breast Cancer Patients using Eribulin\",\"authors\":\"M.X. Su, H.W. Lin, H.T.H. Nguyen, T.C. Lin, C.J. Chen, H.C. Wang, C.T. Wu, Y. Wu, G.Y. He, L.C. Liu, C.H. Huang\",\"doi\":\"10.1016/j.ejca.2024.113705\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":505596,\"journal\":{\"name\":\"European Journal of Cancer\",\"volume\":\"34 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ejca.2024.113705\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.ejca.2024.113705","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}